Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TELA Bio Inc TELA

Healthcare Medical Instruments & Supplies
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall... see more

Recent & Breaking News (NDAQ:TELA)

TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference

GlobeNewswire July 26, 2023

New Survey Finds Strong Consumer Preference for More Natural Hernia Repair Options

GlobeNewswire June 15, 2023

TELA Bio to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire May 25, 2023

TELA Bio Invests in Surgeon Training and Education with Upcoming Cadaver Lab

GlobeNewswire May 19, 2023

TELA Bio Reports First Quarter 2023 Financial Results

GlobeNewswire May 11, 2023

TELA Bio Supports Diversity and Inclusion at International Hernia Collaboration Conference

GlobeNewswire May 9, 2023

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire May 8, 2023

TELA Bio to Participate in the JMP Securities Life Sciences Conference

GlobeNewswire May 2, 2023

TELA Bio to Announce First Quarter 2023 Financial Results

GlobeNewswire April 27, 2023

TELA Bio Announces Pricing of Public Offering of Common Stock

GlobeNewswire April 18, 2023

TELA Bio Announces Proposed Public Offering of Common Stock

GlobeNewswire April 18, 2023

TELA Bio's OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023

GlobeNewswire March 29, 2023

TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

GlobeNewswire March 23, 2023

TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 21, 2023

TELA Bio Highlights Published Clinical Research from 2022 Showcasing Safety and Performance of Reinforced Biologic for Hernia Indications

GlobeNewswire March 16, 2023

TELA Bio to Announce Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire February 28, 2023

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire February 24, 2023

TELA Bio Announces U.S. Commercial Launch of Two New OviTex® LPR Device Configurations to Repair Large Abdominal Hernias Using Robotic and Laparoscopic Techniques

GlobeNewswire February 21, 2023

TELA Bio Awarded Biosynthetic Mesh Products Agreement with a National Group Purchasing Organization

GlobeNewswire February 14, 2023

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire January 20, 2023